Chemotherapy improves thymoma-associated graft-versus-host-disease-like erythroderma

Graft-versus-host-disease (GVHD) with erythroderma can rarely occur in the context of thymoma and is associated with a poor prognosis due to an increased risk of infection-related death. The present study describes a case of a 50-year-old man with malignant thymoma who developed sepsis in addition to skin manifestations similar to that seen in GVHD. This patient experienced marked improvement in skin lesions in response to steroids and combination chemotherapy with carboplatin and paclitaxel, with subsequent resolution of infection. The present study describes the clinical course of this patient, followed by a review of pertinent reports of thymoma associated with GVHD with particular focus on the efficacy of treatment strategies.

[1]  Yukiko Nakamura,et al.  Efficacy of chemotherapy with carboplatin and paclitaxel for unresectable thymic carcinoma. , 2010, Lung cancer.

[2]  N. Saijo,et al.  A phase-II trial of dose-dense chemotherapy in patients with disseminated thymoma: report of a Japan Clinical Oncology Group trial (JCOG 9605) , 2009, British Journal of Cancer.

[3]  C. Langer,et al.  A phase II study of carboplatin plus paclitaxel in advanced thymoma or thymic carcinoma: E1C99 , 2008 .

[4]  Y. Tomita,et al.  Thymoma-associated graft-versus-host disease-like erythroderma. , 2007, Journal of Thoracic Oncology.

[5]  N. Mitsiades,et al.  Thymoma-associated multiorgan autoimmunity: a graft-versus-host-like disease. , 2007, Journal of the American Academy of Dermatology.

[6]  W. Shlomchik,et al.  Graft-versus-host disease , 2007, Nature Reviews Immunology.

[7]  M. Bernstein,et al.  Life-threatening erythroderma: diagnosing and treating the "red man". , 2005, Clinics in dermatology.

[8]  S. Sleijfer,et al.  Full-blown graft-versus-host disease presenting with skin manifestations, jaundice and diarrhoea: an unusual paraneoplastic phenomenon of a thymoma. , 2003, European journal of gastroenterology & hepatology.

[9]  D. Bostwick,et al.  CASE REPORT: Graft-Versus-Host-Like Colitis and Malignant Thymoma , 2002, Digestive Diseases and Sciences.

[10]  M. Edwards,et al.  Graft-versus-host disease-type colitis: an unusual association of malignant thymoma. , 2002, The Annals of thoracic surgery.

[11]  P. Lara.  Malignant thymoma: current status and future directions. , 2000, Cancer treatment reviews.

[12]  直子 加藤,et al.  Graft-Versus-host Disease , 1999 .

[13]  K. Whaley,et al.  Thymoma‐associated cutaneous graft‐versus‐host‐like reaction , 1997, Clinical and experimental dermatology.

[14]  A. Lazenby,et al.  Graft-versus-host-like colitis associated with malignant thymoma. , 1995, The American journal of surgical pathology.

[15]  R. Storb,et al.  A retrospective analysis of therapy for acute graft-versus-host disease: secondary treatment. , 1990, Blood.

[16]  J. Levine,et al.  Chemotherapy of malignant thymoma. Case report and review of the literature , 1986, Cancer.

[17]  Y. Monden,et al.  Follow‐up study of thymomas with special reference to their clinical stages , 1981, Cancer.

[18]  P. Neiman,et al.  CLINICAL MANIFESTATIONS OF GRAFT‐VERSUS-HOST DISEASE IN HUMAN RECIPIENTS OF MARROW FROM HL‐A-MATCHED SIBLING DONOR,S , 1974, Transplantation.

[19]  C. Y. Wang,et al.  Graft-versus-Host disease-like syndrome in malignant thymoma. , 2000, Scandinavian journal of gastroenterology.

[20]  K. Sullivan,et al.  A retrospective analysis of therapy for acute graft-versus-host disease: initial treatment. , 1990, Blood.